Nonin Medical
San Francisco helped U.S.-based Nonin Medical launch the company’s first over-the-counter (OTC) FDA-cleared fingertip pulse oximeter – the TruO2 OTC. The strategically targeted announcement helped strengthen Nonin’s reputation as a global leader in noninvasive medical monitoring solutions and long tradition of bringing cutting-edge medical device technology to consumers and healthcare professionals.
What we did
San Francisco and Nonin Medical’s teams worked together to create compelling messaging and a story around the product, its purpose, the issues and consequences of inaccurate blood oxygen readings and how Nonin’s technology would address those matters. San Francisco pitched the story under embargo to a diverse, but hand-picked selection of media outlets and journalists in the United States. By crafting highly personalised pitches, we were able to gain traction with a varied cross-section of media serving multiple key audiences by emphasising the news’ most relevant impact to their readers.
Media Hits
28
As Seen in
Achievements
San Francisco secured high-quality coverage for the launch in mainstream, local media, and specialised trade media focusing on medical technology and innovations, as well as highly specific medical journals covering niche topics of high relevance to the news. Several journalists also requested interviews with Nonin’s CEO.
Ellie Murphy
Segment Marketing Manager
